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ABSTRACT
Recombinant pollen allergens rPhlp1, rPhlp2, rPhlp5,
and rBetv2 may function as effective markers of atopy
and account for a substantial proportion of grass
pollen-specific IgE. The purpose of the present study
was to determine the frequency of IgE antibodies to
rPhlp1, rPhlp2, rPhlp5 and rBetv2 in patients allergic to
grass pollen. Blood was taken from 436 patients, aged
4–70 years, with allergy to grass. The sample was strat-
ified by 10-year age groups. Specific serum IgE were
measured by the immunoenzymatic CAP Fluoroenzyme
Immunoassay System. Specific IgE binding to rPhlp1,
rPhlp5, rPhlp2, was, respectively, detected in 388
(88.9%), 353 (80.9%) and 265 (60.7%) of 436
patients. Sera from 252 patients (57.7%) showed IgE
binding to rPhlp1, rPhlp2 and rPhlp5; sera from 102
patients (23.3%) reacted to rPhlp1 and rPhlp5, but not
rPhlp2; 30 sera (6.8%) reacted to rPhlp1 but not rPhlp2
and rPhlp5; 22 sera (5.1%) reacted only to rPhlp5; one
serum reacted to rPhlp2 (0.2%); and nine sera (2%) did
not react to recombinant allergens. It was found that
patients in the age group 0–20 years had higher IgE
levels to timothy grass and rPhlp1, rPhlp2 and rPhlp5,
than patients in the older age group (41–60 years). We
found, as expected, seasonal variation of IgE levels to
recombinant allergens and natural allergen. Allergens
rPhlp1, rPhlp2 and rPhlp5 were extremely positively
correlated with timothy grass and rBetv2, but not
rBetv1. These results encourage the use of recom-
binant pollen allergens for diagnosis and to improve
specific immunotherapy in the near future.
Key words: rBetv2, recombinant allergens, rPhlp1,
rPhlp2, rPhlp5, timothy grass.
INTRODUCTION
Allergens constitute one of the most well-defined groups
of biomedically important proteins.
Proteins and glycoproteins derived from pollen grains
are the major source of allergens in the external environ-
ment in temperate climates and between 10 and 25% of
the population show symptoms of hay fever and allergic
asthma.1
Conventional allergen extracts, a heterogeneous
mixture of allergenic and non-allergenic proteins, will
allow neither identification of reactivities to the individual
allergens nor measurement of the amount of specific IgE
against certain allergens.2 For allergologists, further
advances in allergen biotechnology will result in the
development of new products for the diagnosis of allergic
diseases. Currently in vitro, as well in vivo, allergy diag-
nosis can be improved by a component-based system
using recombinant allergens (RA).3
Recently, the complementary DNA coding for the major
timothy grass allergens rPhlp1,4 rPhlp2,5 rPhlp56 and
timothy grass pollen profilin7 were isolated.
The purpose of the present study was to estimate the
frequency of IgE antibodies to RA (rPhlp1, rPhlp2, rPhlp5
and rBetv2) and their natural counterparts, in patients
allergic to grass pollen. In this way, we hoped to establish
whether the determination of RA-specific IgE could be a
helpful tool in the diagnosis of grass pollinosis.
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METHODS
The study involved 436 patients (240 males, mean age
25.6 years, range 4–66, 196 females, mean age 26.5
years, range 4–70) diagnosed as having rhinoconjunc-
tivitis and/or asthma caused by grass pollen. They all had
positive responses to skin-prick test (SPT) performed with
timothy grass pollen extract (Neo Abellò, Madrid, Spain).
The results of SPT were evaluated by European Academy
of Allergology and Clinical Immunology guidelines.8
None of the patients had previously undergone specific
immunotherapy. Out of 436 patients, two subgroups of
subjects were selected during two periods, November–
January (n = 77) and May–July (n = 139), respectively,
to evaluate seasonal variations of specific IgE.
In vitro tests
The RA were supplied by Pharmacia, Uppsala, Sweden.
Specific antibodies to RA (rPhlp1, rPhlp2, rPhlp5,
rBetv1 and rBetv2) and other allergens were measured by
the immunoenzymatic CAP Method (Pharmacia). Specific
IgE tests were considered positive at levels 0.35 kU/L or
higher (‡ class 1).
The distribution of specific IgE to RA and their natural
extract were described as the median and stratified by
10-year age groups.
Statistics
The Mann–Whitney rank sum test was used for unpaired
observations. The coefficient of correlation was calcu-
lated as Spearman’s rho. The significance level chosen
was P < 0.05.
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Table 1 Frequencies of sensitization to recombinant 
allergens rPhlp1 rPhlp2 and rPhlp5 in patients allergic to 
grass pollen
rPhlp1 rPhlp2 rPhlp5 Total patient sensitizations
+ + + 252 (57.7%)
+ – + 102 (23.3%)
+ – – 30 (6.8%)
– – + 22 (5.1%)
+ + – 17 (3.8%)
– – – 9 (2%)
– + + 3 (0.7%)
– + – 1 (0.2%)
n = 436; IgE ‡ 0.35 kU/L. Ta
bl
e
2
M
ed
ia
n 
va
lu
e 
of
 s
er
um
-s
pe
ci
fic
 Ig
E 
to
 d
iff
er
en
t a
lle
rg
en
s
M
ed
ia
n 
(2
5t
h 
–7
5t
h 
pe
rc
en
til
e)
 
0–
70
ye
ar
s 
0–
10
ye
ar
s 
11
–2
0
ye
ar
s 
21
–3
0
ye
ar
s
31
–4
0
ye
ar
s 
41
–5
0
ye
ar
s 
51
–6
0
ye
ar
s 
61
–7
0
ye
ar
s 
(n
=
43
6)
(n
=
34
)
(n
=
14
0)
(n
=
11
8)
(n
=
91
)
(n
=
27
)
(n
=
13
)
(n
=
13
)
rP
hl
p1
13
.6
2 
(<
0.
35
–4
5.
03
)
11
.8
2 
(2
.9
3–
26
.7
4)
15
.8
2 
(3
.6
4–
45
.0
1)
6.
42
 (1
.7
4–
27
.2
3)
6.
01
 (1
.2
8–
16
.3
7)
5.
79
 (1
.6
8–
13
.0
2)
2.
21
 (0
.8
8–
3.
74
)
2.
67
 (<
0.
35
–6
.0
8)
rP
hl
p2
2.
44
 (0
.3
5–
14
.2
4)
2.
71
 (<
0.
35
–1
4.
22
)
3.
21
 (<
0.
35
–1
3.
82
)
0.
92
 (<
0.
35
–7
.7
1)
1.
29
 (<
0.
35
–6
.5
8)
1.
76
 (<
0.
35
–3
.5
3)
4.
59
 (<
0.
35
–5
.3
6)
<
0.
35
 (<
0.
35
–0
.4
7)
rP
hl
p5
3.
32
 (<
0.
35
–3
8.
72
)
3.
7 
(0
.4
3–
27
.6
1)
8.
11
 (0
.4
1–
38
.7
4)
3.
24
 (0
.3
5–
29
.5
2)
1.
89
 (0
.3
6–
18
.2
6)
0.
41
 (<
0.
35
–6
.0
9)
1.
12
 (<
0.
35
–2
.8
8)
<
0.
35
 (<
0.
35
–8
.5
6)
rB
et
v2
0.
53
 (<
0.
35
–4
.5
3)
<
0.
35
 (<
0.
35
–<
0.
35
)
1.
52
 (<
0.
35
–4
.5
4)
0.
52
 (<
0.
35
–2
.3
3)
<
0.
35
 (<
0.
35
–<
0.
35
)
<
0.
35
 (<
0.
35
–0
.4
9)
<
0.
35
 (<
0.
35
–<
0.
35
)
<
0.
35
 (0
.3
5–
0.
35
)
rB
et
v1
4.
51
 (<
0.
35
–3
5.
03
)
<
0.
35
 (<
0.
35
–0
.3
5)
<
0.
35
 (<
0.
35
–4
.2
2)
3.
24
 (<
0.
35
–2
2.
81
)
6.
48
 (<
0.
35
–3
0.
31
)
5.
18
 (<
0.
35
–2
3.
12
)
7.
28
 (0
.5
1–
35
.0
4)
<
0.
35
 (<
0.
35
–8
.0
2)
Ti
m
ot
hy
 
24
.7
1 
(0
.6
4–
>
10
0)
25
.2
4 
(4
.7
3–
>
10
0)
27
.5
1 
(4
.4
4–
89
.7
1)
19
.2
1 
(3
.7
4–
58
.6
1)
10
.4
2 
(3
.1
9–
38
.8
2)
4.
27
 (1
.3
4–
19
.1
4)
4.
06
 (1
.5
8–
18
.2
8)
2.
03
 (0
.5
8–
6.
89
)
gr
as
s
Bi
rc
h
7.
62
 (0
.6
1–
30
.6
4)
3.
32
 (1
.2
4–
10
.6
2)
5.
12
 (1
.5
3–
18
.8
2)
6.
29
 (1
.4
1–
17
.8
9)
8.
88
 (1
.7
4–
30
.6
3)
4.
09
 (0
.7
8–
16
.2
2)
2.
78
 (0
.5
9–
13
.4
9)
2.
93
 (0
.7
9–
9.
18
)
M
ed
ia
n 
va
lu
es
 (k
U
/L
)o
f s
er
um
-s
pe
ci
fic
 Ig
E 
to
 d
iff
er
en
t r
ec
om
bi
na
nt
 a
lle
rg
en
s,
 ti
m
ot
hy
 g
ra
ss
 a
nd
 b
irc
h 
ex
tra
ct
s 
by
 1
0-
ye
ar
 a
ge
 g
ro
up
s 
in
 4
36
 p
at
ie
nt
s 
al
le
rg
ic
 to
 g
ra
ss
 p
ol
le
n,
 2
69
 (6
1.
7%
) o
f
w
hi
ch
 h
ad
 s
pe
ci
fic
 Ig
E 
to
 b
irc
h,
 to
o.
RESULTS
We did not find sex differences in specific IgE to RA (data
not shown). Sera of 57 subjects with CAP-negative IgE to
seven common aeroallergens (mites, cat, timothy grass,
birch, mugwort, pellitory of the walls and Cladosporium
herbarum) did not show specific IgE to individual RA.
The vast majority of subjects with IgE to timothy grass
also had specific IgE to rPhlp1 (388 subjects, 88.9%).
Specific IgE binding to rPhlp5 and rPhlp2 was, respec-
tively, detected in 353 (80.9%) and 265 subjects (60.7%)
of 436 patients. The 228 patients (52.2%) allergic to
grass had specific IgE to Betv2. Of 436 patients allergic
to grass pollen, 269 (61.7%) subjects also had specific
IgE to birch.
Of 436 patients, 252 (57.7%) showed IgE binding 
to rPhlp1, rPhlp2 and rPhlp5; sera from 102 patients
(23.3%) reacted to rPhlp1 and rPhlp5, but not rPhlp2.
The patients were divided into eight groups depending on
the sensitization pattern of RA (Table 1).
Median values of specific IgE levels to rPhlp1, rPhlp2,
rPhlp5, rBetv1, rBetv2, timothy grass and birch are sum-
marized in Table 2.
Seasonal variations of IgE levels to RA and natural
extracts are summarized in Table 3.
In the present study, we found that patients in the age
group 0–20 years had higher IgE levels to timothy grass,
rPhlp1, rPhlp2 and rPhlp5 than patients in the older age
group (Table 4).
As expected, rPhlp1, rPhlp2 and rPhlp5 were extremely
positively correlated with timothy grass and rBetv2 
(profilin), but not rBetv1 (Table 5).
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Table 5 Correlation between specific IgE to allergens from
patients allergic to grass pollen
n r P
rPhlp1 versus
Timothy 230 0.90 <0.001
rBetv2 200 0.43 <0.001
rBetv1 197 0.08 >0.05
rPhlp2 versus
Timothy 230 0.71 <0.001
rBetv2 200 0.31 <0.001
rBetv1 197 0.07 >0.05
rPhlp5 versus
Timothy 230 0.79 <0.001
rBetv2 200 0.47 <0.001
rBetv1 197 0.18 >0.05
Table 4 Median values of serum specific IgE to recombinant allergens by 20-year age groups
0–20 years 41–60 years
(n=174) (n=40) P value
rPhlp1 16.32 (2.88–45.03) 4.68 (1.68–13.04) 0.00005
rPhlp2 4.28 (<0.35–14.18) 2.38 (<0.35–5.38) 0.026
rPhlp5 2.21 (0.41–38.68) 0.78 (<0.35–6.09) 0.00009
Betv2 1.38 (<0.35–4.46) <0.35 (<0.35–0.48) 0.346
Betv1 <0.35 (<0.35–4.18) 5.37 (<0.35–35.02) 0.0032
Timothy grass 27.09 (4.39–>100) 4.34 (1.31–19.14) 0.0351
Birch 4.12 (1.18–18.78) 3.88 (0.57–16.24) 0.023
Measurements are the median (25th –75th percentile), in kU/L. P values were determined using the Mann–Whitney U-test.
Table 3 Median value of serum specific IgE to recombinant allergens, rPhlp1, rPhlp2, rPhlp5, Betv2, Betv1, timothy grass and
birch in two groups of sera obtained from patients before and during the seasonal exposure to grass pollen
May–July (n = 139) November–January (n = 77) P value
rPhlp1 3.88 (0.82–16.33) 10.18 (3.13–32.88) 0.023
rPhlp2 0.97 (<0.35–7.38) 2.48 (<0.35–12.68) 0.113
rPhlp5 1.96 (<0.35–11.04) 2.41 (<0.35–25.38) 0.0451
Betv2 0.37 (<0.35–0.69) <0.35 (<0.35–1.87) 0.002
Betv1 <0.35 (<0.35–0.35) <0.35 (<0.35–0.37) 0.0126
Timothy grass 11.46 (2.57–50.13) 28.84 (4.41–83.77) 0.0009
Birch 0.74 (<0.35–6.97) 0.94 (<0.35–8.46) 0.579
Measurements are the median (25th–75th percentile), in kU/L. P values were determined using the Mann–Whitney U-test.
DISCUSSION
Previously, on evaluating the results of IgE determinations
to rPhlp1 in sera from allergic patients, Laffer et al. had
found that group 1 allergens represent a target for IgE
antibodies in more than 95% of patients allergic to grass
pollen.4,9 In our study, 88.9% of patients allergic to grass
showed specific IgE to rPhlp1. In a recent study, it has
been demonstrated that Phl1 exhibits a trypsin-like prote-
olytic activity when assayed with various test systems and
substrates.10 This observation strongly suggests a possible
cause for the high IgE prevalence in individuals allergic to
group 1 allergens. Group 2 allergens are recognized by
IgE antibodies of 60% of patients allergic to grass
pollen.5 In our patients, 60.7% of sera had detectable
specific IgE antibodies to rPhlp2. Seventy to eighty
percent of patients allergic to grass pollen react to group 
5 allergens.6 Our findings showed that 80.9% of sera
had IgE to rPhlp5. Finally, Vrtala et al. have found that
20% of patients allergic to grass display IgE reactivity to
profilins.11 In our patients, the percentage of sensitization
to rBetv2 was 52.2%. This last difference may be due to
non-uniform selection of study patients and to geo-
graphic differences in the study group.
Another finding of our study is that the patients affected
by grass pollen allergy were divided into eight groups,
depending on the sensitization pattern of rPhlp1, rPhlp2
and rPhlp5. In a group of patients allergic to grass of the
same geographic area, the existence of eight varying 
patterns of IgE production to RA can evoke two consider-
ations: (i) the degree of patient’s sensitization to a single
RA is due to the duration of exposure to major timothy
grass pollen allergen; or (ii) certain patterns of sensitiza-
tion to RA may reflect a genetic background. The levels of
specific IgE of each recombinant allergen are lower than
those of timothy grass (Table 2), because in the natural
counterpart many allergens are simultaneously present.
In fact, timothy grass contains an allergen that has 
not been detected in other grasses, namely Phlp6.12
Moreover, group 4 allergens have been described in a
number of grasses (Phleum pratense, Lolium perenne,
Dactylis glomerata).13
Our findings indicate that subjects in the age group
0–20 years had higher IgE levels to timothy grass and RA
than subjects in the older age group, whereas patients
aged 41–60 years had higher IgE levels against birch
and Betv1 than patients of 0–20 years of age.
Our findings that grass pollen sensitization is associ-
ated with higher IgE than birch allergens may be due 
to a higher exposure to grass. Another possibility is that 
a high specific IgE indicates more activation of the
immune system, resulting in an increased risk of sensiti-
zation to specific allergens, especially in younger age
groups. However, the delayed increase of specific IgE to
birch allergens in the older age group may reflect a
lower, but subcontinuous exposure to Betv1 than to the
grass RA.
Seasonal variation of specific IgE levels to pollen 
allergens are well recognized14 and our data confirm
seasonal significant variations of specific IgE to pollen
extracts and RA.
Further studies with a large number of patient sera as
well as skin-prick test are necessary to further evaluate
the immunologic data and especially confirm the useful-
ness of other RA in the diagnosis of grass pollen allergy.
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